Meet With…Illumina Accelerator and Illumina Ventures
South San Francisco, CA
10:30am - 1:00pm
On April 10th, the Director of Investments at Illumina Ventures, Wouter Meuleman, and the Head of Illumina Accelerator, Amanda Cashin, will give an overview presentation about each group’s key areas of interest including the types of early-stage companies they look for. Following the presentation, you’ll have the opportunity to introduce yourself to Wouter and Amanda during the networking lunch. And finally, for those companies who apply online and are approved, one-on-one meetings with Illumina Ventures (Series A-stage), Illumina Accelerator (Seed-stage), or Illumina, Inc. will be scheduled, providing an intimate forum to discuss your company.
Some areas of interest include:
Genomics Research and Tools
Therapeutics Companies and Discovery Platforms (e.g., Oncology)
Microbial Genomics and Microbiome
Informatics, Genomics Analysis
Illumina Ventures invests in early-stage companies that are pioneering new applications of genomics and enabling precision medicine – including life science tools, clinical diagnostics, and therapeutic platforms. Their limited partners include Illumina, the world’s leading genomics solutions provider, and global corporate, institutional, sovereign, and individual investors. The fund’s team members have spent decades at the forefront of genomics innovation and share a passion for improving human health. For more information, visit http://www.illuminaventures.com.
Illumina Accelerator is the world’s first business accelerator focused solely on creating an innovation ecosystem for the genomics industry. It provides select startups with seed investment, business guidance, access to Illumina’s sequencing systems and reagents, and fully operational lab space in the San Francisco Bay Area during each six-month funding cycle. For more information, visit http://www.illumina.com/accelerator.
Illumina, Inc., is looking for potential partnerships with companies that are advancing the field of genomics and pioneering new applications in healthcare, agriculture, environmental science, and personal wellness. Their goal is to apply innovative technologies to the analysis of genetic variation and function, making studies possible that were not even imaginable just a few years ago. For more information, visit http://www.illumina.com.
Contact: Nikki Sarantinos
Contact Email: email@example.com
JLABS @ SSF
329 Oyster Point Blvd.
South San Francisco, CA